Granted Patent
B2
US 12693297 · App. 17/203,802 · Granted Jul 28, 2026
Coumarin-based crosslinking reagents
Assignee:
Ventana Medical Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Disclosed herein are novel coumarin-based reagents, e.g. linkers, and conjugates including one or more of the disclosed coumarin-based reagents. In some embodiments, the presence of a coumarin moiety within the coumarin-based reagents enables detection of labels which are typically difficult to detect, e.g. certain haptens.
Claims (3)
1 . A compound selected from the group consisting of
2 . A compound selected from the group consisting of
3 . A compound selected from the group consisting of